Hosted on MSN52m
RBC Capital Downgrades Pliant Therapeutics (PLRX)
Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
RBC Capital Sticks to Their Buy Rating for Karyopharm Therapeutics (KPTI)
RBC Capital analyst Brian Abrahams maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) today and set a price target of ...
RBC Capital Raises International Business Machines Corporation (IBM) Price Target to $276, Reaffirms ‘Outperform’ Rating
In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...
Northern Trust Leaders to Participate in RBC Capital Markets Global Financial Institutions Conference
Northern Trust Corporation announced today that Chief Financial Officer David Fox and Wealth Management President Jason Tyler will participate in the RBC 2025 Capital Markets Global Financial ...
U.S. News & World Report1y
RBC Capital Markets LLC
What should I know about this firm? RBC Capital Markets LLC matches individual investors, retirees, families, executives and business owners with a financial advisor based on their money-related ...
Hochschild Mining Shares Tumble on 2025 Capital Expenditure, Cost Guidance
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...
Hosted on MSN10h
AI 'Repeating History,' RBC's Erickson Says
Brad Erickson of RBC Capital Markets discusses the investor outlook for AI as companies continue to bet big on the tech and ...
RBC Capital Remains a Buy on Palo Alto Networks (PANW)
In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Buy rating on Palo Alto Networks (PANW – Research Report), with a ...